CNBM Affirms No Group‐Level Impact After Subsidiary Tianshan Material Restates Prior‐Period Results

Bulletin Express
03/31

China National Building Material Company Limited (CNBM) reported that its Shenzhen-listed subsidiary, Tianshan Material Co., Ltd., has retrospectively corrected accounting errors related to asset disposal gains booked in 2024. The revisions stem from an erroneous interpretation of Chinese Accounting Standards by Jiangshan Southern Cement, a Tianshan Material subsidiary, when recognising gains from a resumption agreement signed in December 2024.

Key restatement effects on Tianshan Material’s consolidated statements are as follows:

• FY 2024: total assets down by RMB139.47 million, total liabilities down by RMB19.94 million, owners’ equity down by RMB119.53 million, and net profit attributable to owners down by RMB119.53 million.

• Q1 2025 and H1 2025: total assets up by RMB8.13 million, total liabilities up by RMB129.92 million, owners’ equity down by RMB121.79 million, and net profit attributable to owners down by RMB2.25 million in each period.

• Q3 2025: total assets up by RMB1.12 million, owners’ equity up by RMB1.12 million, and net profit attributable to owners up by RMB120.66 million.

Da Hua Certified Public Accountants (Special General Partnership) has issued a special assurance report confirming that the adjustments comply with Chinese Accounting Standards.

CNBM stated that, after consulting its auditors, the restatement does not materially affect the group’s audited consolidated financial statements under IFRS for the year ended 31 December 2024, nor its previously released interim financials for 2025. Consequently, no amendments to CNBM’s published accounts are required at this stage.

The group indicated that any further relevant information will be disclosed in accordance with Hong Kong listing rules and other applicable regulations.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10